Showing results (71-80 of 108) with videos related to
Sort By:
Pageof 11
International Journal of Clinical Oncology|February 7, 2002
Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trialD Tassinari, G Drudi, I Panzini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variablesS Ménard, P Valagussa, S Pilotti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancerL Licitra, L D Locati, R Cavina, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 7, 2017
Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumabS M Swain, A Schneeweiss, L Gianni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancerG Grasselli, L Viganò, G Capri, et al.Journal of Chemotherapy (Florence, Italy)|March 20, 2009
Lipoplatin monotherapy: A phase II trial of second-line treatment of metastatic non-small-cell lung cancerA Ravaioli, M Papi, E Pasquini, et al.European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Phase IB and pharmacological study of the novel taxane BMS-184476 in combination with doxorubicinC Sessa, A Perotti, E Salvatorelli, et al.European Journal of Cancer (Oxford, England : 1990)|July 22, 2008
Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumoursS Cresta, C Sessa, C V Catapano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivoA Sparreboom, J Verweij, M E van der Burg, et al.European Journal of Cancer (Oxford, England : 1990)|May 8, 2009
Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumoursC Sessa, S Cresta, C Noberasco, et al.Pageof 11